AU3091597A - Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca) - Google Patents
Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca)Info
- Publication number
- AU3091597A AU3091597A AU30915/97A AU3091597A AU3091597A AU 3091597 A AU3091597 A AU 3091597A AU 30915/97 A AU30915/97 A AU 30915/97A AU 3091597 A AU3091597 A AU 3091597A AU 3091597 A AU3091597 A AU 3091597A
- Authority
- AU
- Australia
- Prior art keywords
- prevention
- treatment
- fudca
- colorectal cancer
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002265 prevention Effects 0.000 title abstract 3
- 206010009944 Colon cancer Diseases 0.000 title abstract 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 3
- 208000003200 Adenoma Diseases 0.000 abstract 1
- 206010001233 Adenoma benign Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000003613 bile acid Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 231100000357 carcinogen Toxicity 0.000 abstract 1
- 239000003183 carcinogenic agent Substances 0.000 abstract 1
- 231100000433 cytotoxic Toxicity 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 abstract 1
- 229960003964 deoxycholic acid Drugs 0.000 abstract 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1820296P | 1996-05-23 | 1996-05-23 | |
| US60018202 | 1996-05-23 | ||
| PCT/EP1997/002632 WO1997044043A1 (en) | 1996-05-23 | 1997-05-22 | Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3091597A true AU3091597A (en) | 1997-12-09 |
Family
ID=21786767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU30915/97A Abandoned AU3091597A (en) | 1996-05-23 | 1997-05-22 | Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca) |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6426340B1 (https=) |
| EP (1) | EP0906106B1 (https=) |
| JP (2) | JP2000510858A (https=) |
| AT (1) | ATE394107T1 (https=) |
| AU (1) | AU3091597A (https=) |
| CA (1) | CA2253593C (https=) |
| DE (1) | DE69738667D1 (https=) |
| ES (1) | ES2306459T3 (https=) |
| PT (1) | PT906106E (https=) |
| WO (1) | WO1997044043A1 (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU758679B2 (en) * | 1998-07-24 | 2003-03-27 | Seo Hong Yoo | Preparation of aqueous clear solution dosage forms with bile acids |
| EP1105141B1 (de) * | 1998-08-06 | 2003-11-05 | Wolfgang Stremmel | Phosphatidylcholin als arzneimittel mit schleimhautschützender wirkung |
| RS50303B (sr) * | 1999-09-28 | 2009-09-08 | Panacea Biotec Limited, | Farmaceutska kompozicija nimesulida sa kontrolisanim oslobađanjem |
| US7053076B2 (en) | 2001-08-29 | 2006-05-30 | Xenoport, Inc. | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| AU2003287300A1 (en) * | 2002-11-01 | 2004-06-07 | James Kaput | Identification of diet-regulated disease-associated genes |
| WO2008088836A2 (en) * | 2007-01-16 | 2008-07-24 | The Burnham Institute For Medical Research | Compositions and methods for treatment of colorectal cancer |
| EP2255813A1 (en) * | 2009-05-29 | 2010-12-01 | The Royal College of Surgeons in Ireland | Derivatives of ursodeoxycholic acid for the treatment of diarrhoea |
| PL3400944T3 (pl) | 2010-11-04 | 2020-11-16 | Albireo Ab | Inhibitory ibat w leczeniu chorób wątroby |
| CA2952406A1 (en) | 2014-06-25 | 2015-12-30 | Ea Pharma Co., Ltd. | Solid formulation and method for preventing or reducing coloration thereof |
| US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
| US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| JP2020530448A (ja) | 2017-08-09 | 2020-10-22 | アルビレオ・アクチボラグ | コレスチラミン顆粒、経口コレスチラミン製剤、及びそれらの使用 |
| US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| ES2942443T3 (es) | 2018-06-05 | 2023-06-01 | Albireo Ab | Compuestos de benzotia(di)azepina y su uso como moduladores de ácidos biliares |
| US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| BR112020024479A2 (pt) | 2018-06-20 | 2021-03-02 | Albireo Ab | hidrato cristalino, modificações cristalinas de odevixibat, solvato misto de odevixibat, uso de modificação cristalina de odevixibat, processo para a preparação de modificação cristalina de odevixibat, e, composição farmacêutica |
| GB201812382D0 (en) | 2018-07-30 | 2018-09-12 | Nzp Uk Ltd | Compounds |
| US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| HUE060905T2 (hu) | 2019-02-06 | 2023-04-28 | Albireo Ab | Benzotiadiazepin vegyületek és azok alkalmazása epesav modulátorként |
| US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
| US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| ES2973549T3 (es) | 2019-12-04 | 2024-06-20 | Albireo Ab | Compuestos de benzoti(di)azepina y su uso como moduladores de los ácidos biliares |
| CN114786772B (zh) | 2019-12-04 | 2024-04-09 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| CA3158181A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| CA3158184A1 (en) | 2019-12-04 | 2021-08-10 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| EP4188541B1 (en) | 2020-08-03 | 2024-12-25 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
| JP2023549226A (ja) | 2020-11-12 | 2023-11-22 | アルビレオ エービー | 進行性家族性肝内胆汁うっ滞症（ｐｆｉｃ）を処置するためのオデビキシバット |
| JP2024500309A (ja) | 2020-12-04 | 2024-01-09 | アルビレオ エービー | ベンゾチア（ジ）アゼピン化合物および胆汁酸モジュレータとしてのその使用 |
| TW202313579A (zh) | 2021-06-03 | 2023-04-01 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8825526D0 (en) * | 1988-11-01 | 1988-12-07 | Enzymatix Ltd | Diagnosis |
| US5175320A (en) * | 1989-04-17 | 1992-12-29 | Giuliani S.P.A. | Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| US5843929A (en) | 1996-03-22 | 1998-12-01 | Mayo Foundation For Medical Education And Research | Chemoprevention of metachronous adenomatous colorectal polyps |
-
1997
- 1997-05-22 ES ES97925934T patent/ES2306459T3/es not_active Expired - Lifetime
- 1997-05-22 AT AT97925934T patent/ATE394107T1/de not_active IP Right Cessation
- 1997-05-22 WO PCT/EP1997/002632 patent/WO1997044043A1/en not_active Ceased
- 1997-05-22 DE DE69738667T patent/DE69738667D1/de not_active Expired - Lifetime
- 1997-05-22 JP JP09541562A patent/JP2000510858A/ja active Pending
- 1997-05-22 EP EP97925934A patent/EP0906106B1/en not_active Expired - Lifetime
- 1997-05-22 CA CA002253593A patent/CA2253593C/en not_active Expired - Fee Related
- 1997-05-22 PT PT97925934T patent/PT906106E/pt unknown
- 1997-05-22 AU AU30915/97A patent/AU3091597A/en not_active Abandoned
-
2000
- 2000-10-06 US US09/684,585 patent/US6426340B1/en not_active Expired - Fee Related
-
2009
- 2009-11-02 JP JP2009252071A patent/JP2010059175A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP0906106A1 (en) | 1999-04-07 |
| JP2010059175A (ja) | 2010-03-18 |
| CA2253593A1 (en) | 1997-11-27 |
| DE69738667D1 (de) | 2008-06-19 |
| JP2000510858A (ja) | 2000-08-22 |
| ATE394107T1 (de) | 2008-05-15 |
| PT906106E (pt) | 2008-08-07 |
| ES2306459T3 (es) | 2008-11-01 |
| WO1997044043A1 (en) | 1997-11-27 |
| US6426340B1 (en) | 2002-07-30 |
| EP0906106B1 (en) | 2008-05-07 |
| CA2253593C (en) | 2008-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3091597A (en) | Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca) | |
| BG102668A (en) | Application of ppar-alpha and prar-gamma antagonist for the treatment of syndrome x | |
| CA2350538A1 (en) | Pyrazolopyrimidinone derivatives for the treatment of impotence | |
| PL325825A1 (en) | Microemulsion for use as a carrier for administering active compounds | |
| CA2370030A1 (en) | Sodium channel blocker compositions and the use thereof | |
| WO1998051294A3 (en) | Method and composition for treating cancers | |
| HRP20020170A2 (en) | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events | |
| WO2001087306A8 (en) | Compositions and methods for the treatment of colorectal cancer | |
| WO2000016762A3 (en) | Method for reducing nicotine dependency | |
| CA2455774A1 (en) | Sugar derivatives of hydromorphone, dihydromorphine and dihydroisomorphine, compositions thereof and uses for treating or preventing pain | |
| AU7239996A (en) | Inhibition of tumor necrosis factor alpha | |
| WO2001030802A3 (en) | Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies | |
| AU7500794A (en) | Novel use of dexmedetomidine | |
| HK1043303A1 (zh) | 阿朴嗎啡在用於治療男性器質性勃起功能障礙的藥物的製備中的應用 | |
| MY121623A (en) | Methods of preventing breast cancer. | |
| CA2326528A1 (en) | Cholesterol sulfate compositions for artificial skin tanning | |
| CA2116829A1 (en) | Use of a pregnane derivative | |
| WO2000029012A8 (en) | Methods of alleviating cancer symptoms | |
| MY126321A (en) | Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer. | |
| PL328123A1 (en) | Derivatives of banzo[c]quinolysine and method of obtaining them | |
| CA2098593A1 (en) | Treatment method for cancer | |
| WO1999065475A3 (en) | Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction | |
| AU3600199A (en) | A pharmaceutical composition containing ezrin mutated on tyrosine 353 | |
| AU6846300A (en) | Use of cyamemazine for cold turkey benzodiazepine treatment | |
| AU2002310920A1 (en) | Pharmaceutical compositions comprising ascomycin |